Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Clinical trial NCT00126581 · COMPLETED

Trial details

NCT number: NCT00126581
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Adenocarcinoma Lung Adenosquamous Carcinoma Malignant Pericardial Effusion Malignant Pleural Effusion Minimally Invasive Lung Adenocarcinoma Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7

Start date: 2005-08-15
Primary completion: 2010-06-30
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.